Skip to content

Sana Biotechnology SANA Derecognition Of Operating Lease Right Of Use Assets For Lease Termination And Modification

Derecognition Of Operating Lease Right Of Use Assets For Lease Termination And Modification at other companies

Boyd Gaming logo
Boyd GamingBYD
$0-100%
Target Hospitality logo
Target HospitalityTH
$3.97M+126%
Highwoods Properties logo
Highwoods PropertiesHIW
$0-100%
Target Hospitality logo
Target HospitalityTH
$3.97M+126%
SEN
Seneca FoodsSENEA
$1.95M
Patterson-UTI Energy logo
Patterson-UTI EnergyPTEN
-$6.37M-1,806%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$912.8M+55.1%
Enterprise value$904.32M+54.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept sana:DerecognitionOfOperatingLeaseRightOfUseAssetsForLeaseTerminationAndModification.

The official record: Sana Biotechnology’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's derecognition of operating lease right of use assets for lease termination and modification.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's derecognition of operating lease right of use assets for lease termination and modification?
Sana Biotechnology (SANA) reported derecognition of operating lease right of use assets for lease termination and modification of -$681K in Q4 2025.
How has Sana Biotechnology's derecognition of operating lease right of use assets for lease termination and modification changed year-over-year?
Sana Biotechnology's derecognition of operating lease right of use assets for lease termination and modification increased by 62.5% year-over-year, from -$1.82M to -$681K.
What is the long-term trend for Sana Biotechnology's derecognition of operating lease right of use assets for lease termination and modification?
Over 2 years (2023 to 2025), Sana Biotechnology's derecognition of operating lease right of use assets for lease termination and modification has grown at a -56.2% compound annual growth rate (CAGR), from -$14.2M to -$2.72M.
What does derecognition of operating lease right of use assets for lease termination and modification mean?
This metric quantifies the reduction in right-of-use assets resulting from the termination or modification of existing lease agreements. It reflects the impact of strategic decisions to exit facilities or downsize physical footprints before the end of the original lease term. This provides insight into management's efforts to optimize operational costs and real estate utilization.